Black Rock Inc. Volitionrx LTD Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Volitionrx LTD stock. As of the latest transaction made, Black Rock Inc. holds 516,073 shares of VNRX stock, worth $325,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
516,073
Previous 573,760
10.05%
Holding current value
$325,125
Previous $436,000
27.98%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VNRX
# of Institutions
26Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$5.67 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$3.84 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA730KShares$460,1820.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$401,1000.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$112,6040.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...